Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BA.2.13ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BA.2.13ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BA.2.13EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BA.2.13EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.2.13ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.13ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.69EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.2.69EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.69ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BA.2.69ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BA.2.69EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BA.2.69EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.2.69ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.69ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.60EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.2.60EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.60ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BA.2.60ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BA.2.60EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BA.2.60EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.2.60ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.60ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.36.35EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.36.35EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.36.35ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.36.35ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.36.35EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.36.35EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.36.35ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.36.35ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.23.1 (Delta)EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
AY.23.1 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.23.1 (Delta)ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
AY.23.1 (Delta)ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
AY.23.1 (Delta)EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
AY.23.1 (Delta)EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
AY.23.1 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.23.1 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.466.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.466.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.466.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.466.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.466.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.466.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.466.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.466.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.213EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.213EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.213ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.213ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used